Comparison of characteristics of intervention group to RA controls at baseline.
| Mean (SD) Control | n (%) Control | Mean (SD) Intervention | n (%) Intervention | |
|---|---|---|---|---|
| Age, yrs | 59 (12) | 61 (8.0) | ||
| Female | 20 (52.6) | 30 (75) | ||
| Seropositive for RF ± anti-CCP | 30 (78.9) | 33 (82.5) | ||
| Erosive | 21 (55.2) | 33 (82.5) | ||
| Disease duration, yrs | 11 (11.2) | 16 (10.9) | ||
| Biologic therapy | 12 (31.5) | 10 (25) | ||
| Smoker | 20 (52.6) | 17 (42.5) | ||
| HAQ | 0.9 (0.4) | 0.8 (0.4) | ||
| Pain (VAS 0–100) | 41.4 (25.5) | 29 (21.5)* | ||
| Stiffness (VAS 0–100) | 43.8 (23.7) | 32 (22.6) | ||
| PSQI | 5.6 (5.2) | 7.2 (4.4) | ||
| Barriers | 31.2 (5.1) | 28.6 (3.2) | ||
| EBBS | 126.3 (21.2) | 125.8 (5.5) | ||
| FSS | 30.5 (15.4) | 29.5 (17.8) |
↵* Indicates significant difference between the groups, other differences are nonsignificant. RA: rheumatoid arthritis; RF: rheumatoid factor; anti-CCP: anticyclic citrullinated peptide antibodies; HAQ: Health Assessment Questionnaire; VAS: visual analog scale; PSQI: Pittsburgh Sleep Quality Index; EBBS: Exercise Benefits and Barriers Scale; FSS: Fatigue Severity Scale.